Procyon Technologies, LLC
https://procyon-technologies.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Procyon Technologies, LLC
Deal Watch: GSK Makes $85m Wager On Surface’s Preclinical NK Cell Therapy
Although SRF813 isn’t likely to reach the clinic until 2021, GSK likes cell therapy’s monotherapy and combination potential. Lilly bids $880m to acquire neurodegenerative cell therapy firm Prevail.
Company Information
- Industry
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Implantable Devices
-
Biotechnology
- Gene Therapy, Cell Therapy
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice